TGK. Breuer, K. Kampmann, A. Wutzler, C. Steinfort, W. Uhl, WE. Schmidt, et al. (2018). [Severe atypical ketoacidosis due to SGLT2-inhibitor therapy : Two case reports]. Der Internist, 59(3), 282-287. https://doi.org/10.1007/s00108-017-0316-y

PubMed 28864828

[Abstract]
Two female patients were admitted due to ketoacidosis. Serum glucose was moderately elevated. The patients exhibited abdominal and neurologic symptoms. Treatment consisted of metformin, insulin glargin and empagliflozin, as well as glimepiride, insulin detemir and empagliflozin, respectively. Treatment with intravenous fluid replacement, insulin, glucose, potassium and buffer solution led to a normalisation of pH and serum glucose levels. Our report describes two cases of atypical ketoacidosis with moderately elevated serum glucose during sodium-glucose co-transporter-2 (SGLT2) inhibitor therapy.